Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 96

Similar articles for PubMed (Select 17229046)

1.

Preanalytical conditions that affect coagulation testing, including hormonal status and therapy.

Blombäck M, Konkle BA, Manco-Johnson MJ, Bremme K, Hellgren M, Kaaja R; ISTH SSC Subcommittee on Women's Health Issues.

J Thromb Haemost. 2007 Apr;5(4):855-8. Epub 2007 Jan 12.

2.

Preanalytical variables and off-site blood collection: influences on the results of the prothrombin time/international normalized ratio test and implications for monitoring of oral anticoagulant therapy.

van Geest-Daalderop JH, Mulder AB, Boonman-de Winter LJ, Hoekstra MM, van den Besselaar AM.

Clin Chem. 2005 Mar;51(3):561-8. Epub 2005 Jan 13.

3.

Quality assessment of CoaguChek point-of-care international normalized ratio monitors: a note of caution.

Kitchen S, Kitchen D, Jennings I, Woods T, Walker I.

Clin Chem. 2007 Aug;53(8):1555-6; author reply 1556-7. No abstract available.

4.

Oral anticoagulant monitoring by laboratory or near-patient testing: what a clinician should be aware of.

Tripodi A, Breukink-Engbers WG, van den Besselaar AM.

Semin Vasc Med. 2003 Aug;3(3):243-54. Review.

PMID:
15199457
5.

International Normalized Ratio in patients not on vitamin K antagonists.

Keeling D.

J Thromb Haemost. 2007 Jan;5(1):188-9. Epub 2006 Oct 25. No abstract available.

PMID:
17067366
6.

Native prothrombin as an alternative to prothrombin time determination for monitoring oral anticoagulant therapy.

Pfäfflin A.

Clin Chem Lab Med. 2009;47(2):242-3. doi: 10.1515/CCLM.2009.046. No abstract available.

PMID:
19191733
7.

Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis.

Pengo V, Tripodi A, Reber G, Rand JH, Ortel TL, Galli M, De Groot PG; Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis.

J Thromb Haemost. 2009 Oct;7(10):1737-40. doi: 10.1111/j.1538-7836.2009.03555.x. Epub 2009 Jul 17.

PMID:
19624461
8.

Influence of plasma volumetric errors on the prothrombin time ratio and International Sensitivity Index.

van den Besselaar AM, Meeuwisse-Braun J, Schaefer-van Mansfeld H, Witteveen E, van Rijn C.

Blood Coagul Fibrinolysis. 1997 Oct;8(7):431-5.

PMID:
9391724
9.

Results of the performance verification of the CoaguChek XS system.

Plesch W, Wolf T, Breitenbeck N, Dikkeschei LD, Cervero A, Perez PL, van den Besselaar AM.

Thromb Res. 2008;123(2):381-9. doi: 10.1016/j.thromres.2008.04.021. Epub 2008 Jun 27.

PMID:
18585761
10.

The significance of the International Normalized Ratio (INR) for oral anticoagulant therapy.

van den Besselaar AM.

J Int Fed Clin Chem. 1991 Sep;3(4):146-53.

PMID:
20821873
11.

Effect of citrate concentration in specimen collection tubes on the International Normalized Ratio.

Danielson CF, Davis K, Jones G, Benson J, Arney K, Martin J.

Arch Pathol Lab Med. 1997 Sep;121(9):956-9. Erratum in: Arch pathol Lab Med 1997 Dec;121(12):2502.

PMID:
9302927
12.
13.
14.

Comparison and evaluation of a Point-of-care device (CoaguChek XS) to Owren-type prothrombin time assay for monitoring of oral anticoagulant therapy with warfarin.

Wieloch M, Hillarp A, Strandberg K, Nilsson C, Svensson PJ.

Thromb Res. 2009 Jul;124(3):344-8. doi: 10.1016/j.thromres.2009.03.007. Epub 2009 May 6.

PMID:
19423152
15.

Reliability of delayed prothrombin time INR determinations in a central laboratory using off-site blood sampling.

Froom P, Abramova D, Bar-El M, Barak M.

Clin Lab Haematol. 2001 Jun;23(3):189-92.

PMID:
11553061
16.
18.
20.

A review of variables affecting PTs/INRs.

McGlasson DL.

Clin Lab Sci. 1999 Nov-Dec;12(6):353-8.

PMID:
10724633
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk